Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,130.00    80.00 (1.13%)
Bid:
7,110.00
Ask:
7,120.00
Spread: 10.00 (0.141%)
Market Cap: £9.56b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Interim Management Statement

17 Jan 2008 07:00

Diploma PLC17 January 2008 12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX TELEPHONE: +44 (0)20 7549 5700 FACSIMILE: +44 (0)20 7549 5715 FOR IMMEDIATE RELEASE 17 January 2008 DIPLOMA PLC INTERIM MANAGEMENT STATEMENT Diploma PLC, the international group of specialised distribution businesses is today issuing its first Interim Management Statement in accordance with the Disclosure and Transparency Rules, issued by the UK Listing Authority, in advance of the Company's AGM to be held today at 12.00 midday. This Statement relates to the period from 1 October 2007 to 31 December 2007 and includes the first quarter's trading. The Board is pleased to report that trading in the first quarter has continued to be positive in each of the Group's core business sectors. The contributions from the three acquisitions completed in August last year have been in line with our expectations and as a result, revenue has increased by over 20% on the comparable period last year. In Life Sciences, the businesses in Europe and Canada have shown steady progress, with the newly acquired AMT business in Canada making a substantial contribution to sales and operating profit. Sales in the Seals businesses have increased on the comparable period last year, despite the uncertain economic background in North America. There have been strong export led performances from the US and UK businesses and the M Seals business in Denmark has made a good contribution in its first full quarter in the Group. The Controls businesses, largely based in Europe, continue to benefit from the specific characteristics of the specialised markets in which they operate. In the UK, sales have increased strongly, reflecting both underlying growth and a good contribution from the newly acquired Cabletec business. In Germany, sales activity remains solid against a strong 2006 comparative when Filcon's connector deliveries peaked on certain major projects. The volatility in the foreign exchange markets continues to impact the Group on translation of the results of the overseas businesses to UK sterling. During the first quarter of the financial year the US$ was 5% weaker, relative to UK sterling, than the comparable period last year. Offsetting this, the C$ and the Euro were 10% and 6% stronger, respectively and therefore the net impact on sales and operating profit from these changes in exchange rates was not significant. The Group's financial position continues to be strong with net cash of £11.0m at 31 December 2007 and undrawn committed term facilities of £20.0m. Pursuant to the Sale and Purchase Agreement for the acquisition of Somagen Diagnostics Inc, dated 15 July 2004, the Group will acquire a further 11.2% of the outstanding shares in Somagen Diagnostics Inc from the minority shareholders for consideration of £3.7m, following the exercise of put/call options, agreed at the time of acquisition in July 2004. On completion of this transaction later this month, the Group's shareholding in Somagen Diagnostics Inc will increase from 80% to 91.2%. There have been no other significant changes in the position of the Group in the period since the publication of the Annual Report for the year ended 30 September 2007. At this stage, the Board believes it is making good progress towards achieving its expectations for the full year. Notes: This Interim Management Statement, which is based upon unaudited management accounts, has been prepared solely to provide additional information to the shareholders of Diploma PLC in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes. Certain statements made in this Statement are forward-looking statements. Such statements have been made by the Directors in good faith using information available up until the date that they approved this Statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks. The next update on trading is expected to be issued as part of the Half Year results for the six months ending 31 March 2008, which are expected to be released on 12 May 2008. A copy of this Statement, together with further information about Diploma, may be viewed on its website at www.diplomaplc.com For further enquiries please contact: Bruce Thompson, Chief Executive Officer 020 7549 5700 Nigel Lingwood, Group Finance Director 020 7549 5705 Ian Seaton, Bankside Consultants 020 7367 8891 NOTE TO EDITORS: Diploma PLC is an international group of specialised distribution businesses operating in three sectors: Life Sciences - suppliers of consumables, instrumentation and related services for research, environmental and clinical applications. Principal companies are Anachem and the a1-envirosciences group in Europe and Somagen and AMT in Canada. Seals - Suppliers of hydraulic seals, kits and components for heavy mobile machinery and industrial applications. Principal companies are the Hercules Fluid Power Group in North America and FPE and M Seals in Europe. Controls - Suppliers of specialised wiring, connectors and control devices for technically demanding applications. Principal companies are the IS-Group in the UK and US, Sommer Filcon in Germany and Hawco in the UK. Within each of these sectors, the Diploma businesses serve industry segments with long term growth potential and with the opportunity for sustainable superior margins through the quality of customer service, depth of technical support and value adding activities. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Feb 202510:34 amRNSHolding(s) in Company
17th Jan 20259:34 amRNSDirector/PDMR Shareholding
15th Jan 20252:56 pmRNSResult of AGM
15th Jan 202510:19 amRNSAppointment of Non-Executive Director
15th Jan 20257:00 amRNS1st Quarter Results
10th Jan 20258:56 amRNSDirector/PDMR Shareholding
23rd Dec 20247:00 amRNSDirector/PDMR Shareholding
9th Dec 20247:00 amRNSAnnual Financial Report & Notice of AGM
5th Dec 20244:25 pmRNSHolding(s) in Company
3rd Dec 20244:39 pmRNSHolding(s) in Company
2nd Dec 20247:00 amRNSTotal Voting Rights
27th Nov 20247:00 amRNSBoard Committee Changes
27th Nov 20247:00 amRNSDirector/PDMR Grant of LTIP Awards
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSPreliminary Results
15th Nov 20247:00 amRNSIssue of Shares & Total Voting Rights
8th Oct 20247:00 amRNSAppointment of Non-Executive Director
13th Sep 20247:00 amRNSAppointment of Senior Independent Director
29th Jul 20242:25 pmRNSDirector Declaration
18th Jul 20247:00 amRNSQ3 Trading Statement
16th Jul 20247:00 amRNSBoard Changes
4th Jun 202411:18 amRNSHolding(s) in Company
13th May 20247:00 amRNSHalf Year Results
2nd May 20247:00 amRNSAcquisition
25th Apr 20243:54 pmRNSHolding(s) in Company
3rd Apr 20247:00 amRNSHolding(s) in Company
27th Mar 20247:00 amRNSAcquisition
5th Mar 20242:07 pmRNSHolding(s) in Company
17th Jan 20243:21 pmRNSResult of AGM
17th Jan 20247:00 amRNSQ1 trading update
20th Dec 20237:00 amRNSAppointment of Non-Executive Director
18th Dec 20237:00 amRNSDirector/PDMR Shareholding
14th Dec 202311:31 amRNSHolding(s) in Company
11th Dec 20237:00 amRNSAnnual Financial Report & Notice of AGM
5th Dec 20233:00 pmRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSTotal Voting Rights
28th Nov 20237:00 amRNSDirector/PDMR Grant of LTIP Awards
21st Nov 20237:00 amRNSDirector/PDMR Shareholding
20th Nov 20237:00 amRNSFull Year Results
16th Nov 20237:00 amRNSIssue of Shares & Total Voting Rights
10th Oct 202312:29 pmRNSHolding(s) in Company
21st Aug 202310:10 amRNSHolding(s) in Company
15th Aug 20233:54 pmRNSHolding(s) in Company
18th Jul 20237:00 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSStrategic acquisition in European Fluid Power
13th Jul 20237:00 amRNSQ3 Trading Update
27th Jun 20237:00 amRNSCapital Markets Seminar
13th Jun 20235:09 pmRNSHolding(s) in Company
7th Jun 20233:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.